AstraZeneca PLC (LON:AZN)
11,416
+220 (1.96%)
Mar 28, 2025, 5:25 PM BST
AstraZeneca Revenue
In the year 2024, AstraZeneca had annual revenue of $54.07B USD with 18.03% growth. AstraZeneca had revenue of $14.89B in the quarter ending December 31, 2024, with 23.84% growth.
Revenue
$54.07B
Revenue Growth
+18.03%
P/S Ratio
4.10
Revenue / Employee
$573.41K
Employees
94,300
Market Cap
177.02B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 54.07B | 8.26B | 18.03% |
Dec 31, 2023 | 45.81B | 1.46B | 3.29% |
Dec 31, 2022 | 44.35B | 6.93B | 18.53% |
Dec 31, 2021 | 37.42B | 10.80B | 40.58% |
Dec 31, 2020 | 26.62B | 2.23B | 9.16% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionAstraZeneca News
- 1 day ago - Japan Approves BridgeBio Pharma-AstraZeneca Partnered Rare Heart Disease Drug - Benzinga
- 1 day ago - Japan Approves BridgeBio Pharma-AstraZeneca Partnered Rare Heart Disease Drug - Benzinga
- 2 days ago - J&J boasts Rybrevant, Lazcluze combo bests AstraZeneca's Tagrisso - Seeking Alpha
- 2 days ago - Lunit to Present AI Study on EGFR Mutation Prediction in NSCLC at AACR 2025 in Collaboration with AstraZeneca - PRNewsWire
- 2 days ago - The women behind life-saving Covid vaccine trials - BBC
- 2 days ago - AstraZeneca's TAGRISSO Shows Promising Results in Lung Cancer Trials - GuruFocus
- 4 days ago - After China probe, is AstraZeneca’s new US$2.5 billion plan a blueprint for foreign firms? - South China Morning Post
- 7 days ago - Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed - Benzinga